Proteinase inhibitors in rheumatoid arthritis.

نویسندگان

  • D Brackertz
  • J Hagmann
  • F Kueppers
چکیده

The concentrations of five normally occurring protease inhibitors in serum and synovial fluid were compared in patients with rheumatoid arthritis, osteoarthrosis, and normal controls. The patients with rheumatoid arthritis showed a significant rise in alpha1-antitrypsin, alpha1-antichymotrypsin, and inter-alpha-trypsin inhibitor (in decreasing order) in serum as well as in synovial fluid. In synovial fluid the inhibitors were present in their native form and bound to hyaluronate. A large molecular protein with immunological specificity of alpha1-antitrypsin, presumably a complex of alpha1-antitrypsin and a protease, could be shown in synovial fluid of all patients with classical and probable rheumatoid arthritis and not in that of the other subjects studied.23Author

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Mini Review: Alpha 1-antitrypsin and Its Involvement In Rheumatoid Arthritis

* Author for correspondence: Dr. (Mrs) Khushtar A Salman, Associate Professor Department of Biochemistry, J.N Medical College, AMU, Aligarh 202002 (U.P), India. Email : [email protected]. Abstract. Rheumatoid arthritis is a common autoimmune disorder, most often affecting women from 40 to 60 years old. The major symptom is chronic inflammation of the joints, although the hematologic, cardiova...

متن کامل

Changes in Glycosylation of Alpha-1-Protease Inhibitor in Inflammation (Rheumatoid Arthritis and Crohn\'s Disease)

Alpha-1-proteinase inhibitor (API) is one of the acute phase proteins. Following an inflammatory stimuli the concentration of API increased up to four folds. Accompanying these quantitative changes, there is qualitative alterations in the structure of carbohydrate moiety (glycosylation). To determine the alterations in the glycosylation of API in inflammation, API was isolated from the sera of...

متن کامل

Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation.

Biological therapies such as tumor necrosis factor-alpha inhibitors have advanced the treatment of rheumatoid arthritis, but one-third of patients do not respond to such therapy. Furthermore, these inhibitors are now usually administered in combination with conventional disease-modifying antirheumatic drugs, suggesting they have not achieved their early promise. This study investigates a novel ...

متن کامل

Side-effects of drugs used in the treatment of rheumatoid arthritis.

A number of anti-inflammatory and other drugs used in the treatment of rheumatoid arthritis have been screened for their ability to cause oxidative damage to lipids and proteins in vitro. Although many drugs exhibited an antioxidant profile, a few drugs tested were pro-oxidant, increasing peroxidation of arachidonic acid by mixtures of haem proteins and H2O2. This system may be an appropriate m...

متن کامل

اثر بروموکریپتین بر علایم بالینی و آزمایشگاهی آرتریت روماتوئید

Background and purpose: Rheumatoid arthritis is a chronic inflammatory disease characterized by articular destruction and systemic complications. The aim of this study was to investigate the effect of bromocriptine on clinical and laboratory findings of rheumatoid arthritis. Materials and methods: Ïn this randomized double-blind placebo-controlled cross-over clinical trial, 10 patients wit...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Annals of the rheumatic diseases

دوره 34 3  شماره 

صفحات  -

تاریخ انتشار 1975